We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

4SC Announces Start of Dosing in First-in-Man Phase I Study with 4SC-203

News   Jan 22, 2010

 
 4SC Announces Start of Dosing in First-in-Man Phase I Study with 4SC-203
 
 
 

RELATED ARTICLES

Even Short-term Vaping Causes Inflammation in Non-smokers, Says Pilot Study

News

Researchers report the first evidence of biological changes correlated with e-cigarette use in never-smokers.

READ MORE

How Do Empty Spaces Make a Protein Unstable?

News

Partial unfolding of proteins may affect their stability and is a challenge in the industry. So how does a cavity destabilize a protein? Would such a cavity be empty? These are questions that researchers from Aarhus University answer in a new study.

READ MORE

Platform Developed To Help Find Treatments for Mental Health Illnesses

News

Scientists have created a drug discovery platform focused on finding new medication options for people dealing with mental illnesses.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery Proteomics & Metabolomics

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE